Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group. Read more about Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group.
Tumor Microenvironment Shapes the Spatial Organization of Glioblastoma Cell States. Read more about Tumor Microenvironment Shapes the Spatial Organization of Glioblastoma Cell States.
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30. Read more about Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30.
Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma. Read more about Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma.
SURG-57. AI-based quantification of tumor infiltration as a major determinant of glioblastoma recurrence and predictive modeling. Read more about SURG-57. AI-based quantification of tumor infiltration as a major determinant of glioblastoma recurrence and predictive modeling.
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Read more about Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Read more about A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative. Read more about Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report. Read more about Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.
